尸检确诊的阿尔茨海默病与路易体病理痴呆患者临终前的临床轨迹
这项回顾性纵向研究纳入62例尸检确诊的痴呆患者(纯AD 34例、AD+DLB混合17例、纯DLB 11例),分析死亡前认知与功能的轨迹。结果发现纯DLB患者的认知和功能下降速度约为纯AD的两倍,混合病理组功能下降速度约为纯AD的两倍。
要点
- 纯DLB患者认知下降速度约为纯AD患者的兩倍。
- 纯DLB患者功能下降速度约为纯AD患者的兩倍。
- AD+DLB混合病理组功能下降速度约为纯AD的兩倍。
核心结论
- 在痴呆患者中,路易体病理患者的认知和功能下降速度快于纯阿尔茨海默病病理患者。
研究设计与样本
- 回顾性纵向研究纳入62例来自Predictors 2队列研究的尸检确诊痴呆患者,其中纯AD 34例、AD+DLB混合17例、纯DLB 11例。
- 采用广义估计方程模型,以死亡时间为零点,分析认知(Folstein简易精神状态检查[MMSE])、功能(日常生活活动[ADL])和依赖量表轨迹,并校正年龄、性别、教育及基线特征。
主要发现
- 参与者平均接受9.4±4.6次评估,间隔6个月,平均随访5.4±2.9年。
- 三组基线认知和功能状态相似。
- 基线时AD+DLB混合组认知与功能高度相关,纯AD或纯DLB组则不相关。
- 三组认知和功能均下降但轨迹不同:纯DLB组认知下降和功能下降速度均约为纯AD组的两倍。
- AD+DLB混合组功能下降速度约为纯AD组的两倍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Evaluating and understanding the heterogeneity in dementia course has important implications for clinical practice, health care decision-making, and research. However, inconsistent findings have been reported with regard to the disease courses of the 2 most common dementias: Alzheimer disease (AD) and dementia with Lewy bodies (DLB). Using autopsy-confirmed diagnoses, we aimed to examine the disease trajectories in the years before death among patients with dementia with pure AD, pure DLB, or mixed (AD and DLB) pathologies. METHODS: The current retrospective longitudinal study included 62 participants with autopsy-confirmed diagnoses of pure AD (n = 34), mixed AD and DLB (AD + DLB; n = 17), or pure DLB (n = 11) from the Predictors 2 Cohort Study, a prospective, clinic-based, cohort of patients with dementia. Generalized estimating equation models, with time zero at death, were used to examine the trajectory of cognition (Folstein Mini-Mental State Examination [MMSE]), function (activities of daily living [ADL]), and Dependence Scale among patients with different autopsy-confirmed diagnosis (pure AD, AD + DLB, and pure DLB). The models were adjusted for age, sex, education, and baseline features including extrapyramidal signs, MMSE, ADL, and Dependence Scale. RESULTS: The participants on average received 9.4 ± 4.6 assessments at 6-month intervals during a mean 5.4 ± 2.9 years of follow-up. The 3 groups were similar in both cognition and function status at baseline. Cognition and function were highly correlated among patients with AD + DLB but not in pure AD or pure DLB at baseline. Patients of the 3 groups all declined in both cognition and function but had different trajectories of decline. More specifically, the patients with pure DLB experienced approximately double the rate of both cognitive decline and functional decline than the patients with pure AD, and the mixed pathology group showed double the rate of functional decline as compared to pure AD. DISCUSSION: In this longitudinal study, we found that among patients with dementia, those with Lewy body pathology experienced faster cognitive and functional decline than those with pure AD pathology.
引用
- Gu Y, Kociolek A, Fernandez KK, et al. Clinical Trajectories at the End of Life in Autopsy-Confirmed Dementia Patients With Alzheimer Disease and Lewy Bodies Pathologies. Neurology. 2022. PMID: 35379761. doi:10.1212/WNL.0000000000200259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。